Sigma Foods (SIGMAF) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
19 Dec, 2025Executive summary
Completed transformation into a single-business structure focused on Sigma, after spinning off Alpek, Axtel, and Nemak, with Alpek now reported as discontinued operations.
Sigma achieved record annual volume, revenue, and EBITDA, surpassing revised guidance, with four consecutive years of sales growth and the highest EBITDA margin in nine years.
Net leverage ratio improved to 2.5x, supported by capital increase, debt reduction, and strong cash flow.
Investment-grade ratings affirmed and upgraded by Fitch to BBB, reflecting improved credit profile.
Paid record dividends totaling US$228 million in 2024.
Financial highlights
2024 consolidated revenue grew 3% year-over-year to US$8.93 billion, driven by Sigma's performance.
2024 reported EBITDA was US$976 million (+14% YoY), with comparable EBITDA at US$1.021 billion (+15% YoY); Sigma's EBITDA surpassed $1 billion for the first time.
Net debt declined by US$2.448 billion in 2024, ending at US$2.47 billion.
Sigma's net debt/EBITDA ratio reached a 16-year low of 1.7x.
Record dividends of US$228 million distributed, supported by strong cash flow.
Outlook and guidance
2025 guidance: revenues of $9.7 billion and EBITDA of $1.1 billion on a currency-neutral basis; CapEx expected to increase 43% year-over-year, prioritizing capacity expansion in Mexico and the U.S.
Margin in Mexico expected around 15% for 2025, with volume growth across all regions.
Alpek spin-off expected to complete in 2025, with ALFA shareholders receiving one share of Controladora Alpek per ALFA share.
Sigma continues to focus on brand expansion, operational efficiency, and marketing innovation, with a new global CMO and design studio partnership.
Alpek expects stable demand and margins in 2025, with continued cost discipline and efficiency initiatives.
Latest events from Sigma Foods
- Record 4Q25 EBITDA, strong innovation, and sustainability progress drive growth outlook.SIGMAF
Corporate presentation25 Feb 2026 - Record 2025 results and Alpek spin-off set up strong 2026 growth and higher dividends.SIGMAF
Q4 202512 Feb 2026 - EBITDA and guidance rose on Sigma's record results, with debt reduction and transformation progressing.SIGMAF
Q2 20242 Feb 2026 - Sigma posts record EBITDA as ALFA advances Alpek spin-off and targets lower leverage.SIGMAF
Q3 202418 Jan 2026 - Record revenues and sequential EBITDA gains despite cost and operational headwinds.SIGMAF
Q3 202514 Dec 2025 - Transformation complete, 1Q25 EBITDA at US$220M, S&P upgrades to 'BBB'.SIGMAF
Q1 202529 Nov 2025 - Record 2Q25 revenues and EBITDA, with insurance gains and strategic transformation completed.SIGMAF
Q2 202513 Nov 2025